Table 3.
Predictors of 60-day Mortality (Multivariable)
| OR | 95% CI | P Value | |
|---|---|---|---|
| Age | 1.034 | 1.030 to 1.039 | .0001 |
| Gender (male versus female) | 1.172 | 0.812 to 1.693 | .3966 |
| Race (white versus others) | 1.417 | 1.251 to 1.605 | .0001 |
| Hypertension | 0.790 | 0.726 to 0.861 | .0001 |
| Diabetes | 0.979 | 0.889 to 1.079 | .6736 |
| Congestive heart failure | 1.688 | 1.536 to 1.854 | .0001 |
| Hyperlipidemia | 0.683 | 0.590 to 0.790 | .0001 |
| Atrial fibrillation | 1.112 | 0.984 to 1.257 | .0880 |
| COPD | 0.947 | 0.857 to 1.046 | .2837 |
| Stroke | 1.682 | 1.238 to 2.286 | .0009 |
| Discharge diagnoses, n | 1.029 | 1.009 to 1.049 | .0043 |
| Charlson Index | 1.707 | 1.533 to 1.901 | .0001 |
| Cardiac catheterization at index | 0.546 | 0.477 to 0.624 | .0001 |
| CABG or PTCA at index | 0.517 | 0.435 to 0.614 | .0001 |
| Region | |||
| MW versus S | 1.069 | 0.965 to 1.185 | .2014 |
| NE versus S | 0.912 | 0.804 to 1.034 | .1515 |
| W versus S | 0.950 | 0.847 to 1.065 | .3747 |
COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; MW, Midwest; NE, Northeast; S, South; W, West.